Stroke News

College graduates may have lower CV risk in middle and older age compared with individuals who did not complete college or high school earlier in life, researchers reported.

Patients who experienced retinal artery occlusion are at higher risk for death, stroke and myocardial infarction in both the short and long term, according to a large retrospective cohort study.

Data show CMS’ Million Hearts CVD Risk Reduction Model, which provided payments for CVD risk assessment and reduction, reduced incidence of first-time MIs and strokes over 5 years without significant changes in Medicare spending.

Good adherence to continuous positive airway pressure therapy may reduce risk for major adverse cardiac and cerebrovascular events in secondary prevention of CVD in patients with obstructive sleep apnea, researchers reported.

Healio and Cardiology Today have compiled a list of the top news in cardiology of September 2023.

Older adults with type 2 diabetes are less likely to have a cardiovascular event if they are initially prescribed an SGLT2 inhibitor or GLP-1 receptor agonist instead of a DPP-IV inhibitor, according to findings published in Diabetes Care.

Genetic predisposition to denture use was associated with increased likelihood of cardiometabolic diseases and related risk factors including dyslipidemia and elevated waist circumference, researchers reported.

Researchers in South Korea showed that statin therapy for treatment-naive patients with already low LDL hospitalized for first-time stroke may reduce risk for all-cause death in the following months.

Anthos Therapeutics announced that the phase 2 AZALEA-TIMI 71 study was stopped early due to an “overwhelming reduction” in bleeding in patients with atrial fibrillation at high risk for stroke taking abelacimab vs. rivaroxaban.

Atrial fibrillation affects 2.7 million to 6.1 million people in the U.S., according to the American Heart Association, and that burden is expected to rise substantially in the coming years.